319
Views
41
CrossRef citations to date
0
Altmetric
Review

Role of acupuncture in the treatment of migraine

, &
Pages 1121-1134 | Published online: 09 Jan 2014

References

  • Burke A, Upchurch DM, Dye C, Chyu L. Acupuncture use in the United States: findings from the National Health Interview Survey. J. Altern. Complement. Med.12(7), 639–648 (2006).
  • Endres HG, Diener HC, Maier C, Böwing G, Trampisch HJ, Zenz M. Acupuncture for the treatment of chronic headaches. Dtsch. Arztebl.104(3), A114–A122 (2007).
  • Göbel H, Petersen-Braun M, Soyka D. The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia14(2), 97–106 (1994).
  • Rasmussen BK. Epidemiology of headache. Cephalalgia21(7), 774–777 (2001).
  • Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. JAMA279(5), 381–383 (1998).
  • Silberstein SD. Preventive treatment of headaches. Curr. Opin. Neurol.18(3), 289–292 (2005).
  • Limmroth V, Diener HC. Neues zu pathophysiologie und therapie der migräne. Notfallmedizin (1,2), 32–41 (2003).
  • Olesen J, Bousser MG, Diener H et al. The International Classification of Headache Disorders (2nd Edition). Cephalalgia24(Suppl. 1), 1–160 (2004).
  • Ernst E. Acupuncture – a critical analysis. J. Intern. Med.259(2), 125–137 (2006).
  • No authors listed. NIH Consensus Conference. Acupuncture. JAMA280(17), 1518–1524 (1998).
  • Limmroth V, Katsarava Z, Liedert B et al. An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system. Pain92(1,2), 101–106 (2001).
  • Weiller C, May A, Limmroth V et al. Brain stem activation in spontaneous human migraine attacks. Nat. Med.1(7), 658–660 (1995).
  • Uddman R, Edvinsson L. Neuropeptides in the cerebral circulation. Cerebrovasc. Brain Metab. Rev.1(3), 230–252 (1989).
  • Hanko J, Hardebo JE, Kahrstrom J, Owman C, Sundler F. Calcitonin gene-related peptide is present in mammalian cerebrovascular nerve fibres and dilates pial and peripheral arteries. Neurosci. Lett.57(1), 91–95 (1985).
  • Moskowitz MA, Macfarlane R. Neurovascular and molecular mechanisms in migraine headaches. Cerebrovasc. Brain Metab. Rev.5(3), 159–177 (1993).
  • Bahra A, Matharu MS, Büchel C, Frackowiak RSJ, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet357, 1016–1017 (2001).
  • Melzack R, Wall PD. Pain mechanisms: a new theory. Science150(699), 971–979 (1965).
  • Carlsson C. Acupuncture mechanisms for clinically relevant long-term effects – reconsideration and a hypothesis. Acupunct. Med.20(2–3), 82–99 (2002).
  • Pielsticker A, Haag G, Zaudig M, Lautenbacher S. Impairment of pain inhibition in chronic tension-type headache. Pain118(1–2), 215–223 (2005).
  • Rossi P, Serrao M, Perrotta A, Pierelli F, Sandrini G, Nappi G. Neurophysiological approach to central pain modulation in primary headaches. J. Headache Pain6(4), 191–194 (2005).
  • Diener HC, Kronfeld K, Boewing G et al. Efficacy of acupuncture for the prophylaxis of migraine: a multicentre randomised controlled clinical trial. Lancet Neurol.5(4), 310–316 (2006).
  • Bingel U, Schoell E, Buchel C. Imaging pain modulation in health and disease. Curr. Opin. Neurol.20(4), 424–431 (2007).
  • Petrovic P, Kalso E, Petersson KM, Ingvar M. Placebo and opioid analgesia-imaging a shared neuronal network. Science295(5560), 1737–1740 (2002).
  • Kong J, Gollub RL, Rosman IS et al. Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J. Neurosci.26(2), 381–388 (2006).
  • Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK. Neurobiological mechanisms of the placebo effect. J. Neurosci.25(45), 10390–10402 (2005).
  • Cheng R, Pomeranz B, Yu G. Dexamethasone partially reduces and 2% saline-treatment abolished electroacupunture analgesia: these findings implicate pituitary endorphins. Life Sci.24(16), 1481–1486 (1979).
  • Pomeranz B, Cheng R, Law P. Acupuncture reduces electrophysiological and behavioral responses to noxious stimuli: pituitary is implicated. Exp. Neurol.54(1), 172–178 (1977).
  • Takeshige C, Kobori M, Hishida F, Luo CP, Usami S. Analgesia inhibitory system involvement in nonacupuncture point-stimulation-produced analgesia. Brain Res. Bull.28(3), 379–391 (1992).
  • Sato T, Usami S, Takeshige C. Role of the arcuate nucleus of the hypothalamus as the descending pain-inhibitory system in acupuncture point and non-point produced analgesia. In: Studies on the Mechanism of Acupuncture Anagesia Based on Animal Experiments. Takeshige C (Ed.). Showa University Press, Tokyo, Japan 542 (1986).
  • Wang Q, Mao L, Han J. The arcuate nucleus of hypothalamus mediates low but not high frequency electroacupuncture analgesia in rats. Brain Res.513(1), 60–66 (1990).
  • Takeshige C, Zhao WH, Guo SY. Convergence from the preoptic area and arcuate nucleus to the median eminence in acupuncture and nonacupuncture point stimulation analgesia. Brain Res. Bull.26(5), 771–778 (1991).
  • Takeshige C, Oka K, Mizuno T et al. The acupuncture point and its connecting central pathway for producing acupuncture analgesia. Brain Res. Bull.30(1–2), 53–67 (1993).
  • Wang QA, Mao LM, Han JS. The role of periaqueductal gray in mediation of analgesia produced by different frequencies electroacupuncture stimulation in rats. Int. J. Neurosci.53(2–4), 167–172 (1990).
  • McLennan H, Gilfillan K, Heap Y. Some pharmacological observations on the analgesia induced by acupuncture in rabbits. Pain3(3), 229–238 (1977).
  • Shen E, Ma WH, Lan C. Involvement of descending inhibition in the effect of acupuncture on the splanchnically evoked potential in the orbital cortex of cat. Sci. Sin.21(5), 677–685 (1978).
  • Cheng RS, Pomeranz B. Monoaminergic mechanism of electroacupuncture analgesia. Brain Res.215(1,2), 77–92 (1981).
  • Han CS, Chou PH, Lu CC, Lu LH, Yang TH, Jen MF. The role of central 5-hydroxytryptamine in acupuncture analgesia. Sci. Sin.22(1), 91–104 (1979).
  • Lao L, Zhang RX, Zhang G, Wang X, Berman BM, Ren K. A parametric study of electroacupuncture on persistent hyperalgesia and Fos protein expression in rats. Brain Res.1020(1,2), 18–29 (2004).
  • Janson W, Stein C. Peripheral opioid analgesia. Curr. Pharm. Biotechnol.4(4), 270–274 (2003).
  • Stein C, Machelska H, Schafer M. Peripheral analgesic and antiinflammatory effects of opioids. Z. Rheumatol.60(6), 416–424 (2001).
  • Ceccherelli F, Gagliardi G, Ruzzante L, Giron G. Acupuncture modulation of capsaicin-induced inflammation: effect of intraperitoneal and local administration of naloxone in rats. A blinded controlled study. J. Altern. Complement. Med.8(3), 341–349 (2002).
  • Moerman DE, Jonas WB. Deconstructing the placebo effect and finding the meaning response. Ann. Int. Med.136(6), 471–476 (2002).
  • Kaptchuk TJ. The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance? Ann. Int. Med.136(11), 817–825 (2002).
  • Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Do medical devices have enhanced placebo effects? J. Clin. Epidemiol.53(8), 786–792 (2000).
  • Wiech K, Kalisch R, Weiskopf N, Pleger B, Stephan KE, Dolan RJ. Anterolateral prefrontal cortex mediates the analgesic effect of expected and perceived control over pain. J. Neurosci.26(44), 11501–11509 (2006).
  • Ploghaus A, Narain C, Beckmann CF et al. Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J. Neurosci.21(24), 9896–9903 (2001).
  • Linde K, Streng A, Jurgens S et al. Acupuncture for patients with migraine: a randomized controlled trial. JAMA293(17), 2118–2125 (2005).
  • Linde K, Witt CM, Streng A et al. The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain128(3), 264–271 (2007).
  • Wager TD, Rilling JK, Smith EE et al. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science303(5661), 1162–1167 (2004).
  • Scharf H-P, Mansmann U, Streitberger K et al. Acupuncture and knee osteoarthritis: a three-armed randomized trial. Ann. Intern. Med.145(1), 12–20 (2006).
  • Pomeranz B, Berman B. Wissenschaftliche Grundlagen der Akupunktur. In: Akupunktur, Lehrbuch und Atlas. Stux G, Stiller N, Berman B, Pomeranz B (Eds). Springer, Berlin, Germany 7–63 (2003).
  • Irnich D, Beyer A. Neurobiological mechanisms of acupuncture analgesia. Schmerz16(2), 93–102 (2002).
  • Vickers AJ, Rees RW, Zollman CE et al. Acupuncture for chronic headache in primary care: large, pragmatic, randomised trial. Br. Med. J.328(7442), 744–749 (2004).
  • Ernst E, White A. Acupuncture: safety first. Br. Med. J.314(7091), 1362 (1997).
  • Vincent C. The safety of acupuncture. Br. Med. J.323(7311), 467–468 (2001).
  • Melchart D, Linde K, Fischer P et al. Acupuncture for idiopathic headache. Cochrane Database Syst. Rev.1, CD001218 (2001).
  • Diener H, Limmroth V. Prevention of migraine: b-blockers and amine agonists: efficacy. In: Preventive Pharmacotherapy of Headache Disorders. Olesen J, Silberstein S, Tfelt-Hansen P (Eds). Oxford University Press, Oxford, UK 59–66 (2004).
  • Melchart D, Hager S, Hager U, Liao J, Weidenhammer W, Linde K. Treatment of patients with chronic headaches in a hospital for traditional Chinese medicine in Germany. A randomised, waiting list controlled trial. Complement. Ther. Med.12(2–3), 71–78 (2004).
  • ICD-10 Guide for Headaches. International Headache Classification Committee. Cephalalgia17(Suppl. 19), 1–82 (1997).
  • Linde M, Fjell A, Carlsson J, Dahlof C. Role of the needling per se in acupuncture as prophylaxis for menstrually related migraine: a randomized placebo-controlled study. Cephalalgia25(1), 41–47 (2005).
  • Allais G, De Lorenzo C, Quirico PE et al. Non-pharmacological approaches to chronic headaches: transcutaneous electrical nerve stimulation, laser therapy and acupuncture in transformed migraine treatment. Neurol. Sci.24(Suppl. 2), S138–S142 (2003).
  • Melchart D, Thormaehlen J, Hager S, Liao J, Linde K, Weidenhammer W. Acupuncture versus placebo versus sumatriptan for early treatment of migraine attacks: a randomized controlled trial. J. Intern. Med.253(2), 181–188 (2003).
  • Streng A, Linde K, Hoppe A et al. Effectiveness and tolerability of acupuncture compared with metoprolol in migraine prophylaxis. Headache46(10), 1492–1502 (2006).
  • Alecrim-Andrade J, Maciel-Junior JA, Cladellas XC, Correa-Filho HR, Machado HC. Acupuncture in migraine prophylaxis: a randomized sham-controlled trial. Cephalalgia26(5), 520–529 (2006).
  • Allais G, De Lorenzo C, Quirico PE et al. Acupuncture in the prophylactic treatment of migraine without aura: a comparison with flunarizine. Headache42(9), 855–861 (2002).
  • Tfelt-Hansen P, Block G, Dahlof C et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia20(9), 765–786 (2000).
  • Diener HC. Headache. Curr. Opin. Neurol.18(3), 279–282 (2005).
  • Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Chronic migraine is an earlier stage of transformed migraine in adults. Neurology65(10), 1556–1561 (2005).
  • Headache Classification Subcommittee of the International Headache Society (IHS). The International Classification of Headache Disorders (2nd edition). Cephalalgia24(Suppl. 1), 9–160 (2004).
  • Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia8(Suppl. 7), 1–93 (1988).
  • Göbel H. Classification of headache: criteria and practical implementation. Z. Arztl. Fortbild.87(6), 451–458 (1993).

Website

  • Deutsches Ärzteblatt www.aerzteblatt.de/v4/archiv/english.asp?q=1&y=2007

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.